RSNA 2014 

Abstract Archives of the RSNA, 2014


SSK15-05

Palliative Treatment of Painful Bone Metastases with MR Imaging–guided Focused Ultrasound Surgery: A Two-centre Study

Scientific Papers

Presented on December 3, 2014
Presented as part of SSK15: Musculoskeletal (Interventional)

Participants

Alessandro Napoli MD, Presenter: Nothing to Disclose
Alberto Bazzocchi MD, Abstract Co-Author: Nothing to Disclose
giulia brachetti, Abstract Co-Author: Nothing to Disclose
Gaia Cartocci MD, Abstract Co-Author: Nothing to Disclose
Paolo Spinnato MD, Abstract Co-Author: Nothing to Disclose
Ugo Albisinni MD, Abstract Co-Author: Nothing to Disclose

PURPOSE

To evaluate the efficacy of non-invasive high intensity MR guided focused Ultrasound Surgery (MRgFUS) for pain palliation of bone metastasis in patients who had exhausted EBRT or refused other therapeutic options. 

METHOD AND MATERIALS

this prospective, single arm, two-centre study received IRB approval. 72 patients (female: 24, male: 48, mean age: 61.6) with painful bone metastases were enrolled. 87 non-spinal lesions underwent MRgFUS treatment using ExAblate 2100 system (InSightec). European Organization for Research and Treatment of Cancer QLQ- BM22 was used for clinical assessment additionally to Visual Analog Scale (VAS), at baseline and 1,3 and 6 months after treatment. All patients underwent CT and MRI before treatment and 3-6 months afterward. 

RESULTS

No treatment-related adverse events were recorded. 34/72 (47.2%) patients reported complete response to treatment and discontinued medications. 29/72 (40.3%) experienced a pain score reduction >2 points, consistent with partial response. Remaining 9 (12.5%) patients had recurrence after treatment. Statistically significant differences between baseline (6, 95%CI 5-8) and follow-up (2, 95%CI 0-3) VAS values and medication intake were observed (p<0.05). Similarly a significant difference was found for QLQ- BM22 between baseline and follow-up (p<0.05). 

CONCLUSION

MRgFUS can be safely and effectively be adopted for treatment of painful bone metastases.

CLINICAL RELEVANCE/APPLICATION

MRgFUS can be safely and effectively used as totally noninvasive treatment for pain palliation of bone metastasis in patients who had exhausted EBRT and also in patients not previously treated with EBRT. 

Cite This Abstract

Napoli, A, Bazzocchi, A, brachetti, g, Cartocci, G, Spinnato, P, Albisinni, U, Palliative Treatment of Painful Bone Metastases with MR Imaging–guided Focused Ultrasound Surgery: A Two-centre Study.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14019372.html